🇺🇸 FDA
Pipeline program

SNUBH-NM-333(18F)

SNUBH-NM-333(18F)

Phase 2 other terminated

Quick answer

SNUBH-NM-333(18F) for Alzheimer Disease is a Phase 2 program (other) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Alzheimer Disease
Phase
Phase 2
Modality
other
Status
terminated

Clinical trials